New treatment may cure common hormonal cause of high blood pressure
A small study found that extended treatment with the aldosterone synthase inhibitor baxdrostat led to sustained blood pressure reduction for up to two years after patients stopped taking the drug.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A study led by Queen Mary University of London and published in the New England Journal of Medicine found that a new treatment approach could offer a lasting cure for some people with primary aldosteronism, a hormonal cause of high blood pressure. The treatment, called extended aldosterone synthase inhibition (EASI), involves taking aldosterone synthase inhibitors such as baxdrostat for 6–12 months to target excess production of the hormone aldosterone. Unlike conventional treatments that control blood pressure, EASI appears to reverse the underlying cause, potentially removing the need for lifelong medication. Until now, a cure has required surgery to remove an entire adrenal gland.
The study followed 14 people treated at eight centers across the United States. Researchers found that EASI treatment led to sustained reversal of excess aldosterone production and partial or complete resolution of high blood pressure for up to two years after treatment ended. Hormone levels and blood pressure remained similar to, or lower than, those recorded during treatment. The main marker of excess aldosterone production remained 99% lower than before treatment, while blood pressure was, on average, 25 points lower. Almost a quarter of participants had normal blood pressure without taking any other medication.
Primary aldosteronism, in which benign nodules in the adrenal glands produce too much aldosterone, causes the kidneys to retain excess salt, raising blood pressure. It is estimated that between 5% and 10% of hypertension cases are caused by this condition. The scientific basis for EASI dates back to a 2005 experiment in mice showing that deleting the gene for aldosterone synthase caused aldosterone-producing cells to disappear. Researchers predicted prolonged inhibitor treatment might have a similar effect in humans.
Morris Brown, lead author and professor of endocrine hypertension at Queen Mary, said, "While duly cautious about our findings because of the pragmatic nature of the study, they were predicted by previous experiments, and longer follow-up may justify a claim that a finite course of medication leads to infinite cure. EASI treatment is unlikely to be the elixir for most patients with hypertension. But the possibility of tablets achieving a surgical cure has long been a holy grail for this common type of hypertension." Mason Freeman, professor of medicine at Harvard Medical School and initiator of the original study, said the follow-up generated "extraordinary and unexpected findings" offering "the very exciting possibility that many patients with primary aldosteronism may be able to be treated with a once-a-day pill, perhaps for a limited period of time, and obtain similar benefits to what we now achieve only after invasive diagnostic testing and major adrenal surgery."
In the United Kingdom, the drug is being assessed by the National Institute for Health and Care Excellence (NICE). Building on these findings, researchers are now leading a larger prospective clinical trial called ELIXIR to investigate whether EASI treatment can provide a lasting cure and will use molecular imaging to study whether prolonged treatment causes aldosterone-producing cells to disappear.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (95% supported) Updated 8d ago.
Quick answers
What is the new treatment for primary aldosteronism?
The treatment is called extended aldosterone synthase inhibition (EASI), which involves taking aldosterone synthase inhibitors such as baxdrostat for 6–12 months to target excess aldosterone production.
How long did the benefits last after patients stopped taking the drug?
The study found that sustained reversal of excess aldosterone production and partial or complete resolution of high blood pressure persisted for up to two years after treatment ended.
What percentage of hypertension cases are caused by primary aldosteronism?
It is estimated that between 5% and 10% of hypertension cases are caused by primary aldosteronism.
Coverage (8)
- Novel drug therapy may cure common hormonal cause of high blood pressure Open Access Government · 9d ago
- New high blood pressure pill that ‘cures’ the condition could be available in 2027 The Sun · 10d ago
- Pharma stocks: Why AstraZeneca (LSE:AZN) is setting the tone for UK healthcare Kalkine Media · 10d ago
- New drug that could permanently cure high blood pressure coming to UK by 2027 The i Paper · 10d ago
- Pharma stocks: Why baxdrostat matters for AstraZeneca (LSE:AZN) Kalkine Media · 10d ago
- Baxdrostat’s effect persisted for up to two years after treatment UA.NEWS · 10d ago
- New drug could be cure for common cause of high blood pressure The Guardian · 10d ago
- New treatment may cure common hormonal cause of high blood pressure Medical Xpress · 10d ago
Topics
Related trends
New drug could be cure for common cause of high blood pressure
EU medicines panel recommends AstraZeneca's baxdrostat for uncontrolled hypertension, while new research suggests a potential cure for hormone-driven high blood pressure.
Survival after sudden cardiac arrest didn’t improve despite training bystanders, emergency responders
A five-year North Carolina trial found that expanding CPR training, 911 dispatcher coaching, and early defibrillation across 31 counties did not improve survival after out-of-hospital cardiac arrest compared with 29 counties using usual care.
Opportunistically Detecting Signs of Hypertension on a Consumer Smartwatch
Recent coverage examines how consumer smartwatches and AI might opportunistically detect signs of high blood pressure.
Your Blood Pressure Could Be Higher Than You Think. These 7 Fruits May Help Bring It Down, Say Experts
Medical experts and dieticians are highlighting specific fruits and vegetables, including pomegranates and beetroots, to help lower high blood pressure.
Millions of people high blood pressure pills daily, now scientists are testing a small device that stimul
British researchers have tested a small ear-clip nerve stimulation device as a potential alternative to daily blood pressure medication.
More Than Half of People With This Serious Heart Health Risk Don’t Even Know They Have It, New Study Says
A new study indicates over half of individuals with a serious heart risk remain unaware of their condition.